See the DrugPatentWatch profile for Rystiggo
The price of Rystiggo (aderamente) is not publicly disclosed by the manufacturer, UCB. Drug pricing is complex and can vary based on several factors, including insurance coverage, pharmacy, and patient assistance programs.
How is the cost of Rystiggo determined?
The list price of a medication like Rystiggo is set by the pharmaceutical company. However, the actual out-of-pocket cost for patients is influenced by their insurance plan, which dictates co-pays, deductibles, and whether the drug is covered. Patient assistance programs may also be available to help offset costs for eligible individuals.
What is Rystiggo used for?
Rystiggo is approved for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive. gMG is a chronic autoimmune neuromuscular disease characterized by fluctuating weakness of voluntary muscles [1].
How does Rystiggo work?
Rystiggo is a neonatal Fc receptor (FcRn) antagonist [1]. By blocking the FcRn receptor, it reduces the levels of disease-causing IgG antibodies, including anti-AChR antibodies, which are implicated in the pathology of gMG [2].
When did Rystiggo receive approval?
Rystiggo received approval from the U.S. Food and Drug Administration (FDA) in June 2023 [1].
What is the clinical data supporting Rystiggo's use?
Clinical trials demonstrated that Rystiggo significantly improved outcomes in patients with gMG. In the Phase 3 MYSTERY-3 study, Rystiggo showed a statistically significant improvement in the primary endpoint, the Myasthenia Gravis-Activities of Daily Living (MG-ADL) score, compared to placebo at Week 26 [1].
Are there alternatives to Rystiggo for myasthenia gravis?
Yes, there are other treatment options for generalized myasthenia gravis. These include immunosuppressants like corticosteroids, azathioprine, and mycophenolate mofetil. Plasma exchange and intravenous immunoglobulin (IVIg) are short-term treatment options. Additionally, newer therapies targeting specific immune pathways are available or in development [3].
What is the patent status for Rystiggo?
Information regarding specific patents for Rystiggo and their expiration dates can be found on specialized patent tracking websites. DrugPatentWatch.com provides a database of drug patents and exclusivity information [4].